1. Home
  2. DTIL vs BWG Comparison

DTIL vs BWG Comparison

Compare DTIL & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTIL
  • BWG
  • Stock Information
  • Founded
  • DTIL 2006
  • BWG 2012
  • Country
  • DTIL United States
  • BWG United States
  • Employees
  • DTIL N/A
  • BWG N/A
  • Industry
  • DTIL Biotechnology: Pharmaceutical Preparations
  • BWG Finance/Investors Services
  • Sector
  • DTIL Health Care
  • BWG Finance
  • Exchange
  • DTIL Nasdaq
  • BWG Nasdaq
  • Market Cap
  • DTIL 120.4M
  • BWG 139.9M
  • IPO Year
  • DTIL 2019
  • BWG N/A
  • Fundamental
  • Price
  • DTIL $5.09
  • BWG $8.32
  • Analyst Decision
  • DTIL Strong Buy
  • BWG
  • Analyst Count
  • DTIL 2
  • BWG 0
  • Target Price
  • DTIL $47.00
  • BWG N/A
  • AVG Volume (30 Days)
  • DTIL 251.8K
  • BWG 53.8K
  • Earning Date
  • DTIL 11-03-2025
  • BWG 01-01-0001
  • Dividend Yield
  • DTIL N/A
  • BWG 11.37%
  • EPS Growth
  • DTIL N/A
  • BWG N/A
  • EPS
  • DTIL N/A
  • BWG N/A
  • Revenue
  • DTIL $698,000.00
  • BWG N/A
  • Revenue This Year
  • DTIL N/A
  • BWG N/A
  • Revenue Next Year
  • DTIL $135.19
  • BWG N/A
  • P/E Ratio
  • DTIL N/A
  • BWG N/A
  • Revenue Growth
  • DTIL N/A
  • BWG N/A
  • 52 Week Low
  • DTIL $3.61
  • BWG $6.86
  • 52 Week High
  • DTIL $8.82
  • BWG $8.65
  • Technical
  • Relative Strength Index (RSI)
  • DTIL 37.99
  • BWG 43.61
  • Support Level
  • DTIL $4.86
  • BWG $8.23
  • Resistance Level
  • DTIL $5.27
  • BWG $8.33
  • Average True Range (ATR)
  • DTIL 0.42
  • BWG 0.11
  • MACD
  • DTIL -0.14
  • BWG 0.00
  • Stochastic Oscillator
  • DTIL 23.58
  • BWG 52.10

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.

BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.

Share on Social Networks: